SD

Shashi Dev

Active Director Director DIN 10463470
DIN 10463470 First appointment Jan 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value •••• Premium profile

About Shashi Dev

Data last updated:

Shashi Dev is a Director at Duowell Pharmaceuticals Private Limited (since 2024). The company operates in Pharma. Duowell Pharmaceuticals Private Limited reported revenue of ₹20 Lakh (FY 2025).

DIN 10463470
Primary Designation Director
Industry Pharma
First Appointment 12 Jan 2024
Oldest Company Age 2 yrs
Largest company Duowell Pharmaceuticals Private Limited · ₹20 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director12 Jan 20242024₹20 Lakh (FY 2025)Active

Board colleagues of Shashi Dev

NameDINCompanyDesignation
Kedar Nath Dalabehara10463469Duowell Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Duowell Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Shashi Dev

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shashi Dev

Shashi Dev currently holds 1 directorship: Duowell Pharmaceuticals Private Limited (Director, since 12 Jan 2024, revenue ₹20 Lakh (FY 2025)).

Shashi Dev was first appointed on 12 Jan 2024 as Director at Duowell Pharmaceuticals Private Limited.

The current boards of Shashi Dev's companies include Kedar Nath Dalabehara (Duowell Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available